Pangrol (Pancreas Powder)

Pancreas Powder is thought to consist of pancreatic enzymes that facilitate the breakdown of proteins, fats, and carbohydrates in the gastrointestinal tract. By providing exogenous enzymes, it may augment the body's natural digestive capacity, but the precise biochemical targets and pathways have not been disclosed in publicly available sources.

The appropriate dose of Pangrol is determined by the prescribing healthcare professional based on the intended use, patient characteristics, and clinical judgment. No standard dosing regimen is published, and the prescriber should tailor the amount to the specific therapeutic or investigational context.

Safety data for Pangrol in pregnancy or lactation have not been established. It should only be used when the potential benefit justifies any possible risk to the mother or infant, and this decision must be made under the guidance of a qualified healthcare provider.

To order Pangrol, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials before providing pricing, availability, shipping details and any required import documentation.

While specific comparative data are not publicly available, Pangrol’s Pancreas Powder can be viewed alongside other pancreatic enzyme preparations that contain lipase, amylase and protease. Differences may relate to enzyme potency, source material, formulation (e.g., enteric‑coated tablets versus powders) and regulatory status, so clinicians should evaluate each product based on the clinical need.

Pangrol should be stored at ambient temperature, preferably below 25 °C, in its original container to protect it from moisture and light. Keep the product out of reach of children and handle with clean, dry hands or gloves to avoid accidental ingestion or contamination.

Pangrol is intended for oral administration. The powder can be mixed with a small amount of water, juice, or soft food as directed by the prescriber. It should be taken according to the healthcare professional’s instructions, typically with meals to aid digestion.

The most serious potential risks include severe allergic reactions such as anaphylaxis and possible exacerbation of existing pancreatic disorders. Although rare, these events require immediate medical attention. Patients should be monitored for signs of hypersensitivity, abdominal pain, or worsening digestive symptoms.

Individuals with a known hypersensitivity to pancreatic enzymes or any component of the formulation should avoid Pangrol. It is also contraindicated in patients with active pancreatitis or severe pancreatic insufficiency unless specifically prescribed by a specialist who has evaluated the risk‑benefit profile.